Abstract
Background: The impact of bifurcations at the proximal or distal cap on the outcomes of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) has received limited study. Methods: We analyzed the clinical, angiographic, and procedural data of 4,584 cases performed in patients between 2012 and 2020 in a global CTO PCI registry. We compared 4 groups according to the bifurcation location: “proximal cap,” “distal cap,” “proximal and distal cap,” and “no bifurcation.” Results: The CTO involved a bifurcation in 67% cases, as follows: proximal cap (n = 1451, 33%), distal cap (n = 622, 14%), or both caps (n = 954, 21%). “Proximal and distal cap” cases had higher J-CTO compared with “proximal cap,” “distal cap,” and “no bifurcation” cases (2.9 ± 1.1 vs 2.5 ± 1.1 vs 2.4 ± 1.2 vs 2.0 ± 1.2, P < 0.0001), and they were also associated with a lower technical success rate (79% vs 85% vs 85% vs 90%, P < 0.0001), higher pericardiocentesis rate (1% vs 1% vs 0.2% vs 0.3%, P = 0.02), and higher emergency coronary artery bypass graft surgery rate (0.3% vs 0% vs 0% vs 0%, P = 0.01). Conclusion: More than two-thirds of CTO PCIs involve a bifurcation, which is associated with lower technical success and higher risk of complications.
Original language | English (US) |
---|---|
Pages (from-to) | 80-83 |
Number of pages | 4 |
Journal | Hellenic Journal of Cardiology |
Volume | 66 |
DOIs | |
State | Published - Jul 1 2022 |
Funding
Dr. Nikolakopoulos: nothing to disclose; Dr. Vemmou: nothing to disclose; Dr. Karacsonyi: nothing to disclose; Dr. Alaswad: consulting fees from Terumo and Boston Scientific; consultant, no financial, Abbott Laboratories; Dr. Karmpaliotis: speaker honoraria: Abbott Vascular, Boston Scientific, Medtronic, Vascular Solutions. Dr. Poomimanit: proctor—Asahi Intecc, Inc, proctor—Abbott Vascular, and faculty—Medtronic National Fellows Course; Dr. Abi Rafeh: proctor and speaker honoraria from Boston Scientific and Abbott Vascula; Dr.ElGuindy: proctorship fees from Boston Scientific; Dr. Burke: shareholder in Egg Medical and MHI Ventures; Dr. Brilakis: consulting/speaker honoraria from Abbott Vascular, American Heart Association (associate editor Circulation), Amgen, Asahi Intecc, Biotronik, Boston Scientific, Cardiovascular Innovations Foundation (Board of Directors), CSI, Elsevier, GE Healthcare, IMDS, Medicure, Medtronic, Siemens, and Teleflex; research support: Boston Scientific, GE Healthcare; owner, Hippocrates LLC; shareholder: MHI Ventures, Cleerly Health, Stallion Medical.
Keywords
- bifurcation
- chronic total occlusion
- percutaneous coronary intervention
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine